Two billion dirhams net profits "Purehealth" During 2025
Abu Dhabi, February 9, 2025 – PureHealth Holding announced its financial results for the fiscal year ending December 31, 2025, where net profits grew by 17.7% compared to last year to reach 2 billion dirhams, and profits before tax increased by 26.1% on an annual basis to reach 2.2 billion dirhams, and the group proposed distributing profits worth 600 million dirhams for the year. 2025, subject to obtaining regulatory and shareholder approval.
The group’s revenues reached 27.3 billion dirhams during 2025, an increase of 5.7% compared to last year, driven by strong performance in the care and insurance sectors.
Earnings before deducting interest, taxes and depreciation also increased by 16.1% compared to last year to reach 4.8 billion dirhams, as a result of the continuous improvement in operational efficiency, integration between operations and the contribution of the “Helink Healthcare” group during the fourth quarter of 2025, following the recent acquisitions in Greece and Cyprus.
This performance supports the proposal to distribute profits worth 600 million dirhams for the fiscal year 2025, equivalent to about 30% of net profits, to be distributed in two equal semi-annual installments.
The distribution proposal reflects PureHealth’s balance sheet strength, recurring earnings base, and sustainable ability to generate cash flows across various industry conditions.
The proposed dividend distribution framework also reflects the deliberate expansion of the “Pure Health” platform locally and internationally, the sustainability of financial performance, and discipline in allocating capital, at a time when “Pure Health” continues to implement its long-term growth strategy, as a global healthcare group.
PureHealth operates in the UAE, the United States of America, the United Kingdom, Greece and Cyprus, driven by the growing demand for healthcare services, the expansion of clinical capacity, and the provision of specialized medical services, in addition to continued investment in healthcare solutions supported by artificial intelligence.
His Excellency Kamal Al-Mazmi, Chairman of the Board of Directors of Pure Health, said that the year 2025 represents a pivotal station in Pure Health’s journey towards building an integrated global healthcare group, supported by technology and innovation.
He added that with the expansion of PureHealth into strategic international markets and the strengthening of its capabilities in the areas of specialized care locally, the foundations for a more interconnected, stronger and more flexible health care system are being laid, noting that the policy proposal for distributing profits reflects the confidence of the Board of Directors in the financial strength that PureHealth has succeeded in building, and its commitment to providing sustainable value to shareholders, while at the same time maintaining the flexibility necessary to invest in long-term growth.
For his part, Farhan Malak, founder and managing director of the PureHealth Group, said that the resilient financial performance and strength of the balance sheet form the basis of the group’s disciplined approach to deploying capital, whether through investing in technology and artificial intelligence and enhancing absorptive capacity, or through qualitative, value-enhancing acquisitions. The group continues to achieve stronger returns for shareholders, while transferring the best health care standards to the UAE and the markets that we serve.
He added that with about 50% of assets outside the UAE today, Pure Health has become a global group with diversified revenues across multiple markets and currencies, pointing out that this performance gives the group the ability to reward shareholders with a dividend distribution worth 600 million dirhams, while continuing to invest in the next phase of Pure Health’s expansion locally and globally.
For her part, Shaista Asif, CEO of Pure Health Group, confirmed that the results of 2025 reflect the ability of PureHealth’s care and insurance model to transform operational volume into profits, strong cash flows, and tangible integration across various markets, pointing to achieving strong growth in the UAE, along with great momentum in the United Kingdom, through the Circle Health Group, in addition to the success in integrating its recent acquisition of the Hellenic Healthcare Group, in Greece and Cyprus.
Asif pointed out that the range of digital solutions and artificial intelligence applications implemented by the group contributes to creating an exceptional platform that distinguishes it from major global health authorities, and qualifies it to lead the era of health care supported by artificial intelligence.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
